Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications

Anupa R. Menjoge, Kannan Rangaramanujam, Donald A. Tomalia

Research output: Contribution to journalArticle

Abstract

Dendrimers are members of a versatile, fourth new class of polymer architecture (i.e. dendritic polymers after traditional linear, crosslinked and branched types) [1]. Typically, dendrimers are used as well-defined scaffolding or nanocontainers to conjugate, complex or encapsulate therapeutic drugs or imaging moieties. As a delivery vector, the dendrimer conjugate linker or spacer chemistry plays a crucial part in determining optimum drug delivery to disease sites by conserving active drug efficacy while influencing appropriate release patterns. This review focuses on several crucial issues related to those dendrimer features, namely the role of dendrimers as nanoscaffolding and nanocontainers, crucial principles that might be invoked for improving dendrimer cytotoxicity properties, understanding dendrimer cellular transport mechanisms and the exciting role of dendrimers as high-contrast MRI imaging agents. The review concludes with a brief survey of translational efforts from research and development phases to clinical trials that are actively emerging.

Original languageEnglish (US)
Pages (from-to)171-185
Number of pages15
JournalDrug Discovery Today
Volume15
Issue number5-6
DOIs
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Dendrimers
Pharmaceutical Preparations
Translational Medical Research
Catalytic Domain
Polymers
Clinical Trials

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Dendrimer-based drug and imaging conjugates : design considerations for nanomedical applications. / Menjoge, Anupa R.; Rangaramanujam, Kannan; Tomalia, Donald A.

In: Drug Discovery Today, Vol. 15, No. 5-6, 03.2010, p. 171-185.

Research output: Contribution to journalArticle

@article{b2e86d77df89494abd8e20c22aec341b,
title = "Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications",
abstract = "Dendrimers are members of a versatile, fourth new class of polymer architecture (i.e. dendritic polymers after traditional linear, crosslinked and branched types) [1]. Typically, dendrimers are used as well-defined scaffolding or nanocontainers to conjugate, complex or encapsulate therapeutic drugs or imaging moieties. As a delivery vector, the dendrimer conjugate linker or spacer chemistry plays a crucial part in determining optimum drug delivery to disease sites by conserving active drug efficacy while influencing appropriate release patterns. This review focuses on several crucial issues related to those dendrimer features, namely the role of dendrimers as nanoscaffolding and nanocontainers, crucial principles that might be invoked for improving dendrimer cytotoxicity properties, understanding dendrimer cellular transport mechanisms and the exciting role of dendrimers as high-contrast MRI imaging agents. The review concludes with a brief survey of translational efforts from research and development phases to clinical trials that are actively emerging.",
author = "Menjoge, {Anupa R.} and Kannan Rangaramanujam and Tomalia, {Donald A.}",
year = "2010",
month = "3",
doi = "10.1016/j.drudis.2010.01.009",
language = "English (US)",
volume = "15",
pages = "171--185",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "5-6",

}

TY - JOUR

T1 - Dendrimer-based drug and imaging conjugates

T2 - design considerations for nanomedical applications

AU - Menjoge, Anupa R.

AU - Rangaramanujam, Kannan

AU - Tomalia, Donald A.

PY - 2010/3

Y1 - 2010/3

N2 - Dendrimers are members of a versatile, fourth new class of polymer architecture (i.e. dendritic polymers after traditional linear, crosslinked and branched types) [1]. Typically, dendrimers are used as well-defined scaffolding or nanocontainers to conjugate, complex or encapsulate therapeutic drugs or imaging moieties. As a delivery vector, the dendrimer conjugate linker or spacer chemistry plays a crucial part in determining optimum drug delivery to disease sites by conserving active drug efficacy while influencing appropriate release patterns. This review focuses on several crucial issues related to those dendrimer features, namely the role of dendrimers as nanoscaffolding and nanocontainers, crucial principles that might be invoked for improving dendrimer cytotoxicity properties, understanding dendrimer cellular transport mechanisms and the exciting role of dendrimers as high-contrast MRI imaging agents. The review concludes with a brief survey of translational efforts from research and development phases to clinical trials that are actively emerging.

AB - Dendrimers are members of a versatile, fourth new class of polymer architecture (i.e. dendritic polymers after traditional linear, crosslinked and branched types) [1]. Typically, dendrimers are used as well-defined scaffolding or nanocontainers to conjugate, complex or encapsulate therapeutic drugs or imaging moieties. As a delivery vector, the dendrimer conjugate linker or spacer chemistry plays a crucial part in determining optimum drug delivery to disease sites by conserving active drug efficacy while influencing appropriate release patterns. This review focuses on several crucial issues related to those dendrimer features, namely the role of dendrimers as nanoscaffolding and nanocontainers, crucial principles that might be invoked for improving dendrimer cytotoxicity properties, understanding dendrimer cellular transport mechanisms and the exciting role of dendrimers as high-contrast MRI imaging agents. The review concludes with a brief survey of translational efforts from research and development phases to clinical trials that are actively emerging.

UR - http://www.scopus.com/inward/record.url?scp=77949275122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949275122&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2010.01.009

DO - 10.1016/j.drudis.2010.01.009

M3 - Article

C2 - 20116448

AN - SCOPUS:77949275122

VL - 15

SP - 171

EP - 185

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 5-6

ER -